In Sanskrit, the word Prana means breath, vital force, and spirit. It has long been known that as we age, our capacity to breath (and therefore move oxygen, CO2, and stressful thought) diminishes. That is why it has been a key measured biomarker of aging in our Patton Protocol patients taking TA-65.
So in a sense, good health is like keeping a bathtub full of clean water. The supply of water is nearly endless if we can keep the mesenchymal stem cell library frozen in our cartilage from aging when recruited. And if we can drain out the foul water (mutated stem cells), then we are going to be just fine.
Men who developed cancers were compared with those that didn’t for the 13 years prior to diagnosis or exclusion by using a quantitative PCR measurement (which is problematic). Firstly, they found was two different curves with the cancer group showing a more rapid shortening trend. This is consistent with my stem cell theory of aging and most of the extant studies.
When data from the Copehnhagen City Heart Study was published in 2013, they concluded that shorter telomeres in leukocytes was not associated with increased cancer after adjusting for age but that it WAS associated with reduced survival from cancer http://jnci.oxfordjournals.org/content/105/7/459.long
In 2015, the same data looked at certain gene tendencies that promote telomere shortening and concluded that cancer survival was IMPROVED when shortening was enhanced in the telomeres.
Contradiction? Not so fast.
I was asked for the 1,000th time today whether telomerase causes cancer since it is present in 85% of cancers. I found this interesting article supporting my focus on a cancer stem cell model- that is to say not all cancer cells are immortal either and there are special ones that retain their super-powers, like flying.
For those wanting a more in-depth understanding of how TA-65 might work, I refer to you an email conversation I had with a patient, who was concerned that a blog referenced a Blasco paper demonstrating a 50% increase in liver cancer in mice after taking TA-65.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
